Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion type Assertion NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_head.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion description "[Expressions of 5- and 12-LOX in prostate cancer (PC) patients, prostatic intraepithelial neoplasia (PIN), benign prostatic hyperplasia (BPH), and normal prostate (NP) tissues were examined, as well as effects of their inhibitors on cell proliferation in 2 PC cell lines (PC3, DU-145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_provenance.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion evidence source_evidence_literature NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_provenance.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion SIO_000772 15010818 NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_provenance.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion wasDerivedFrom befree-2016 NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_provenance.
- NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_assertion wasGeneratedBy ECO_0000203 NP434961.RAF3veatSr12x4E4CqqLyt5KPPSQ1I1mdgH3Q22C2VGS0130_provenance.